Kimberly A Stigler

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. doi request reprint Paliperidone for irritability in adolescents and young adults with autistic disorder
    Kimberly A Stigler
    Section of Child and Adolescent Psychiatry, Department of Psychiatry, Indiana University School of Medicine, Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, 705 Riley Hospital Drive, Indianapolis, IN 46202 5200, USA
    Psychopharmacology (Berl) 223:237-45. 2012
  2. pmc Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study
    Kimberly A Stigler
    Department of Psychiatry, Section of Child and Adolescent Psychiatry, Indiana University School of Medicine and Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202 5200, USA
    J Child Adolesc Psychopharmacol 19:265-74. 2009
  3. ncbi request reprint Ramelteon for insomnia in two youths with autistic disorder
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine and the Christian Sarkine Autism Treatment Center at the James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202 5200, USA
    J Child Adolesc Psychopharmacol 16:631-6. 2006
  4. pmc Structural and functional magnetic resonance imaging of autism spectrum disorders
    Kimberly A Stigler
    Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202 5200, USA
    Brain Res 1380:146-61. 2011
  5. doi request reprint A prospective open-label study of aripiprazole in fragile X syndrome
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, 702 Barnhill Drive, Indianapolis, IN 46202, USA
    Psychopharmacology (Berl) 216:85-90. 2011
  6. ncbi request reprint Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders
    Christopher J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202 4800, USA
    J Clin Psychiatry 69:15-20. 2008
  7. pmc The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders
    Jason G Ho
    Section of Pediatric Cardiology, Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana 46202 5200, USA
    J Child Adolesc Psychopharmacol 22:277-83. 2012
  8. ncbi request reprint Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders
    David J Posey
    Department of Psychiatry and Christian Sarkine Autism Treatment Center at the Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Child Adolesc Psychopharmacol 16:599-610. 2006
  9. ncbi request reprint A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders
    Adam H Corson
    Department of Psychiatry, Indiana University School of Medicine and Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, Ind 46202 4800, USA
    J Clin Psychiatry 65:1531-6. 2004
  10. doi request reprint Pharmacotherapy of irritability in pervasive developmental disorders
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine, Riley Hospital for Children, Room 4300, 702 Barnhill Drive, Indianapolis, IN 46202 5200, USA
    Child Adolesc Psychiatr Clin N Am 17:739-52, vii-viii. 2008

Collaborators

Detail Information

Publications26

  1. doi request reprint Paliperidone for irritability in adolescents and young adults with autistic disorder
    Kimberly A Stigler
    Section of Child and Adolescent Psychiatry, Department of Psychiatry, Indiana University School of Medicine, Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, 705 Riley Hospital Drive, Indianapolis, IN 46202 5200, USA
    Psychopharmacology (Berl) 223:237-45. 2012
    ..Despite advances in the treatment of this symptom domain in autism, there remains an ongoing need for more effective and better tolerated pharmacotherapies...
  2. pmc Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study
    Kimberly A Stigler
    Department of Psychiatry, Section of Child and Adolescent Psychiatry, Indiana University School of Medicine and Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202 5200, USA
    J Child Adolesc Psychopharmacol 19:265-74. 2009
    ..The aim of this study was to determine the effectiveness and tolerability of aripiprazole for irritability in pervasive developmental disorder not otherwise specified (PDD-NOS) and Asperger's disorder...
  3. ncbi request reprint Ramelteon for insomnia in two youths with autistic disorder
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine and the Christian Sarkine Autism Treatment Center at the James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202 5200, USA
    J Child Adolesc Psychopharmacol 16:631-6. 2006
    ..The aim of this study was to report preliminary data on the effectiveness and tolerability of ramelteon for the treatment of insomnia in youth with autistic disorder (autism)...
  4. pmc Structural and functional magnetic resonance imaging of autism spectrum disorders
    Kimberly A Stigler
    Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202 5200, USA
    Brain Res 1380:146-61. 2011
    ..Overall, structural and functional MRI research has generated important insights into the neurobiology of ASDs. Additional research is needed to further delineate the underlying brain basis of this constellation of disorders...
  5. doi request reprint A prospective open-label study of aripiprazole in fragile X syndrome
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, 702 Barnhill Drive, Indianapolis, IN 46202, USA
    Psychopharmacology (Berl) 216:85-90. 2011
    ..Despite frequent clinical use of atypical antipsychotic drugs to target this behavioral cluster, no systematic trials to date have assessed the efficacy and safety of these drugs in persons with FXS...
  6. ncbi request reprint Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders
    Christopher J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202 4800, USA
    J Clin Psychiatry 69:15-20. 2008
    ..Additional placebo-controlled trials and studies of longer-term safety and tolerability are needed...
  7. pmc The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders
    Jason G Ho
    Section of Pediatric Cardiology, Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana 46202 5200, USA
    J Child Adolesc Psychopharmacol 22:277-83. 2012
    ..Adult studies have evaluated aripiprazole's effects on electrocardiograms, but no pediatric studies have been published to date...
  8. ncbi request reprint Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders
    David J Posey
    Department of Psychiatry and Christian Sarkine Autism Treatment Center at the Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Child Adolesc Psychopharmacol 16:599-610. 2006
    ..The aim of this study was to conduct an initial evaluation of the efficacy of atomoxetine for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with pervasive developmental disorders (PDDs)...
  9. ncbi request reprint A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders
    Adam H Corson
    Department of Psychiatry, Indiana University School of Medicine and Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, Ind 46202 4800, USA
    J Clin Psychiatry 65:1531-6. 2004
    ..The purpose of this study was to examine the effectiveness and tolerability of quetiapine for aggression, hyperactivity, and self-injury in pervasive developmental disorders (PDDs)...
  10. doi request reprint Pharmacotherapy of irritability in pervasive developmental disorders
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine, Riley Hospital for Children, Room 4300, 702 Barnhill Drive, Indianapolis, IN 46202 5200, USA
    Child Adolesc Psychiatr Clin N Am 17:739-52, vii-viii. 2008
    ..Additional large-scale, placebo-controlled studies of other medications are needed to determine their efficacy for the treatment of irritability in this diagnostic group...
  11. pmc An open-label naturalistic pilot study of acamprosate in youth with autistic disorder
    Craig A Erickson
    Department of Psychiatry, Christian Sarkine Autism Treatment Center, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202, USA
    J Child Adolesc Psychopharmacol 21:565-9. 2011
    ..Acamprosate was well tolerated with only mild gastrointestinal adverse effects noted in three (50%) subjects...
  12. pmc Antipsychotics in the treatment of autism
    David J Posey
    Christian Sarkine Autism Treatment Center, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    J Clin Invest 118:6-14. 2008
    ..Significant adverse effects, including weight gain and the possibility of tardive dyskinesia, are reviewed. Future research directions are discussed...
  13. ncbi request reprint Risperidone in pervasive developmental disorders
    Craig A Erickson
    Riley Hospital, Child and Adolescent Psychiatry Clinic, 702 Barnhill Drive, ROC 4300, Indianapolis, IN 46202, USA
    Expert Rev Neurother 5:713-9. 2005
    ..Finally, a discussion of the future direction of risperidone use in this population and key issues will be presented...
  14. ncbi request reprint A retrospective study of memantine in children and adolescents with pervasive developmental disorders
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA
    Psychopharmacology (Berl) 191:141-7. 2007
    ..There are no drugs that have been shown to effectively treat the core social impairment of autism...
  15. pmc Aripiprazole in autism spectrum disorders and fragile X syndrome
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Neurotherapeutics 7:258-63. 2010
    ..However, research to date in this disorder has not focused on this target symptom cluster. An initial pilot study has begun to assess the impact of aripiprazole on irritability in youth with fragile X syndrome...
  16. doi request reprint Open-label riluzole in fragile X syndrome
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202, USA
    Brain Res 1380:264-70. 2011
    ..Correction of delayed ERK activation is a potential biomarker of treatment response in FXS. We conducted a six-week open-label prospective pilot study of riluzole (100 mg/day) in six adults with FXS...
  17. ncbi request reprint Pharmacologic treatment of autism and related disorders
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, and the Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis 46202 4800, USA
    Pediatr Ann 36:575-85. 2007
  18. ncbi request reprint Aripiprazole for maladaptive behavior in pervasive developmental disorders
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine and the James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202, USA
    J Child Adolesc Psychopharmacol 14:455-63. 2004
    ..The aim of this study was to obtain preliminary data regarding the effectiveness and tolerability of aripiprazole in the treatment of children and adolescents with a pervasive developmental disorder (PDD)...
  19. ncbi request reprint The use of selective serotonin reuptake inhibitors in autism and related disorders
    David J Posey
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    J Child Adolesc Psychopharmacol 16:181-6. 2006
    ..Larger, placebo-controlled studies of SSRIs are needed to guide clinical treatment...
  20. ncbi request reprint A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana, USA
    J Child Adolesc Psychopharmacol 14:49-56. 2004
    ..We set out to examine the effectiveness and tolerability of psychostimulants in children and adolescents with pervasive developmental disorders (PDDs)...
  21. ncbi request reprint Gastrointestinal factors in autistic disorder: a critical review
    Craig A Erickson
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis 46202 4800, USA
    J Autism Dev Disord 35:713-27. 2005
    ..While much literature is available on this topic, a dearth of rigorous study was found to validate GI factors specific to children with autism...
  22. ncbi request reprint Neurochemistry in the pathophysiology of autism
    Christopher J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202 4800, USA
    J Clin Psychiatry 66:9-18. 2005
    ..As these efforts move forward, it will be important to begin to integrate genetic studies with those involving neuroimaging and postmortem research in each of these 3 areas, as well as with pharmacologic treatment approaches...
  23. pmc Emerging drugs for the treatment of symptoms associated with autism spectrum disorders
    Logan K Wink
    Indiana University School of Medicine, Department of Psychiatry, Indianapolis, IN 46202, USA
    Expert Opin Emerg Drugs 15:481-94. 2010
    ..The use of pharmacologic agents in the treatment of these disorders can reduce the impact of interfering symptoms, providing relief for affected individuals and their families...
  24. ncbi request reprint Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management
    Kimberly A Stigler
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202 4800, USA
    Paediatr Drugs 6:33-44. 2004
    ....
  25. ncbi request reprint Treatment of aggression in children and adolescents with autism and conduct disorder
    Christopher J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Clin Psychiatry 64:16-25. 2003
    ....
  26. pmc Developmental disabilities modification of the Children's Global Assessment Scale
    Ann Wagner
    National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA
    Biol Psychiatry 61:504-11. 2007
    ..To measure global functioning in treatment studies, the Children's Global Assessment Scale was modified and psychometric properties of the revised version (DD-CGAS) were assessed in children with PDD...